Adverse Event Reporting
| VAERS ID | 984528 |
|---|---|
| Gender | Female |
| Age | |
| StateCode | PA |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | |
| Number of vaccinations | 1 |
| Vaccinated | |
| Onset | |
| Condition |
Symptoms
- Exposure via breast milk
- Menstruation irregular
Current Illness
Preexisting Conditions
Medical History/Concurrent Conditions: Absence of menstruation
Other Medications
Previous Vaccinations
Allergies
Laboratory Data
Write-up
one woman has been breastfeeding; early menses after receiving the vaccine; This is a spontaneous report from a Pfizer sponsored program, from a contactable consumer.
This consumer reported information for both mother and baby.
This is the maternal report.
A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization.
Medical history included "has not had a period since 2019".
The patient's concomitant medications were not reported.
The patient had early menses after receiving the vaccine.
She has been breastfeeding.
Outcome of the event "early menses after receiving the vaccine" was unknown.
Information on lot number/batch number was requested.